Toggle navigation
Home
Search
Services
Blog
Contact
About
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Opioids with Delta Antagonist and Mu Agonist Activity
Human Dimorphisms by Sine Master Genes
A Novel Improvement on Radiotherapy for Scchn
SATB1 in T Cell Apoptosis
Engineered Control of Cellular Aging
Recently added grants:
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
Northwestern University Lead Academic Participating Site
UM LAPs - UG1 Grant
UG1 - NCTN (Network Lead)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N02CM72202-2-0-1
Application #
7590582
Study Section
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N02 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/ Research Triangle Institute
$688,286
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations
Hines, John /
$622,262
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/
Comments
Be the first to comment on this grant